Compumedics Limited (ASX:CMP)
Australia · Delayed Price · Currency is AUD 0.2300
-0.0050 (-2.13%)
Sep 17, 2026, 2:56 PM AEST
Compumedics Revenue
In the fiscal year ending June 30, 2026, Compumedics had annual revenue of 61.88M AUD with 21.23% growth. Compumedics had revenue of 30.90M in the half year ending June 30, 2026, with 29.57% growth.
Revenue
61.88M
Revenue Growth
+21.23%
P/S Ratio
0.74
Revenue / Employee
353.58K
Employees
175
Market Cap
45.95M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 61.88M | 10.84M | 21.23% |
| Jun 30, 2025 | 51.04M | 778.00K | 1.55% |
| Jun 30, 2024 | 50.26M | 7.34M | 17.10% |
| Jun 30, 2023 | 42.92M | 4.32M | 11.18% |
| Jun 30, 2022 | 38.61M | 2.87M | 8.02% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Saluda Medical | 130.35M |
| SomnoMed | 114.53M |
| Nova Eye Medical | 34.87M |
| Cyclopharm | 34.42M |
| CleanSpace Holdings | 19.82M |
| Lumos Diagnostics Holdings | 19.07M |
| OncoSil Medical | 5.09M |
| Control Bionics | 4.77M |